Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEWTON: A Single-center Open Label Study Evaluating Intravitreal Aflibercept Injection (IAI) for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions

NCT01870427 is registered in ClinicalTrials.gov with Northern California Retina Vitreous Associates as lead sponsor.

NCT NCT01870427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01870427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEWTON: A Single-center Open Label Study Evaluating Intravitreal Aflibercept Injection (IAI) for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions
Lead sponsor
Northern California Retina Vitreous Associates
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2013
Completion date
August 31, 2016
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema with central retinal vein occlusions